4//SEC Filing
Charlton Ralph William III 4
Accession 0001209191-22-060278
CIK 0001683553other
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 8:06 PM ET
Size
5.8 KB
Accession
0001209191-22-060278
Insider Transaction Report
Form 4
Charlton Ralph William III
Chief Medical Officer
Transactions
- Award
Restricted Stock Units
2022-12-05+127,000→ 127,000 totalExercise: $0.00→ Common Stock (127,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer.
- [F2]The RSUs vest over four years. 25% of the RSUs will vest on December 15, 2023 (the "Annual Vesting Date"), and 25% of the total number of RSUs will vest in annual installments on each anniversary of the Annual Vesting Date thereafter, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan).
Documents
Issuer
SPRUCE BIOSCIENCES, INC.
CIK 0001683553
Entity typeother
Related Parties
1- filerCIK 0001919397
Filing Metadata
- Form type
- 4
- Filed
- Dec 6, 7:00 PM ET
- Accepted
- Dec 7, 8:06 PM ET
- Size
- 5.8 KB